Consensus Enlivex Börse Stuttgart

Stocks

1BT

IL0011319527

Real-time Estimate Tradegate Other stock markets 23:33:56 16/07/2026 +04			5-day change	1st Jan Change
4.310 ^EUR	-10.21%		-23.81%	-47.54%

06-15	Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis	MT
06-01	Enlivex Ltd. Presents Durable 6-Month Efficacy Data For Allocetra In Knee Osteoarthritis Phase IIa Trial	CI

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

ca7b501fbe1f2b736810e13aa8.2RjWlAcQhW5qkCjdj5Ylu-NrBiwSC2R0j2uLh9ShG6A.7Syyw1RowAQT3H68wOVj15oNMGFqQz4OxibY5eyUfpWDfuCndXfxPRPVSw~e643e46c0f8972e1370b17af91e99a81

Analysts' recommendations: Enlivex

11/06/24	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
12/04/24	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
25/09/23	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
02/05/22	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

5.840USD

Average target price

300.00USD

Spread / Average Target

+5,036.98%

High Price Target

300.00USD

Spread / Highest target

+5,036.98%

Low Price Target

300.00USD

Spread / Lowest Target

+5,036.98%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

5.840USD

Average target price

300.00USD

Spread / Average Target

+5,036.98%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Google lets you customize your preferred sources.

G Google

Choose MarketScreener

G Google

Choose MarketScreener